Multiple Effects of SGLT2 Inhibitors

被引：0
|
作者：
Nagasu, Hajime [1 ]
机构：
[1] Kawasaki Med Sch, Dept Nephrol & Hypertens, Okayama, Japan
来源：
JMA JOURNAL | 2024年
关键词：
SGLT2; inhibitor; hyperkalemia; acute kidney injury; anemia; chronic kidney disease;
D O I：
10.31662/jamj.2024-0229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adverse effects of SGLT2 inhibitors on bone health
    Jenny E. Blau
    Simeon I. Taylor
    Nature Reviews Nephrology, 2018, 14 : 473 - 474
  • [32] Cardiac effects of SGLT2 inhibitors: the sodium hypothesis
    Bertero, Edoardo
    Roma, Leticia Prates
    Ameri, Pietro
    Maack, Christoph
    CARDIOVASCULAR RESEARCH, 2018, 114 (01) : 12 - 18
  • [33] Possible adverse effects of SGLT2 inhibitors on bone
    Taylor, Simeon I.
    Blau, Jenny E.
    Rother, Kristina I.
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (01): : 8 - 10
  • [34] The effects of SGLT2 inhibitors on myoblast proliferation and myogenesis
    Kwak, Mi Kyung
    Ha, Eun Sook
    Choe, Hun Jee
    Lee, Jiwoo
    Choi, Yun Mi
    Hong, Eun-Gyoung
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 92 - 93
  • [35] Effects of SGLT2 inhibitors on cardiac structure and function
    Giuseppina Novo
    Tommaso Guarino
    Daniela Di Lisi
    Paolo Biagioli
    Erberto Carluccio
    Heart Failure Reviews, 2023, 28 : 697 - 707
  • [36] Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
    Vallon, Volker
    Verma, Subodh
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 83, 2021, 83 : 503 - 528
  • [37] SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses
    Filippatos, Theodosios D.
    Liontos, Angelos
    Papakitsou, Ioanna
    Elisaf, Moses S.
    POSTGRADUATE MEDICINE, 2019, 131 (02) : 82 - 88
  • [38] Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes
    Muskiet, Marcel H. A.
    van Bommel, Erik J. M.
    van Raalte, Daniel H.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03): : 188 - 189
  • [39] Development of SGLT1 and SGLT2 inhibitors
    Timo Rieg
    Volker Vallon
    Diabetologia, 2018, 61 : 2079 - 2086
  • [40] Development of SGLT1 and SGLT2 inhibitors
    Rieg, Timo
    Vallon, Volker
    DIABETOLOGIA, 2018, 61 (10) : 2079 - 2086
12345